跳至主要内容
临床试验/NCT00737880
NCT00737880已完成4 期

A Prospective Randomized Multicenter Trial Comparing Histidine-Tryptophane-Ketoglutarate (HTK) Versus University of Wisconsin (UW) Perfusion Solution in Clinical Pancreas Transplantation

Medical University Innsbruck8 个研究点 分布在 3 个国家目标入组 68 人开始时间: 2001年7月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
68
试验地点
8
主要终点
Pancreas graft survival

研究概览

简要总结

Graft preservation in clinical pancreas transplantation is based on hypothermia achieved by topic cooling and cold in situ flushing using special perfusion solutions designed to attenuate the effects of ischemia/reperfusion and prolong cold ischemia tolerance.

For pancreas transplantation, University of Wisconsin (UW) solution is the most commonly used perfusate. However, over the last years, Histidine-Tryptophan-Ketoglutarate (HTK) solution has been increasingly used for abdominal organ procurement. Retrospective reports published so far have demonstrated the safety of both perfusion solutions.

However, to date, no prospective study comparing both perfusion solutions has been published. Aim of this study was to prospectively evaluate early pancreas graft function in clinical pancreas transplantation after organ perfusion with HTK vs. UW solution.

The study hypothesis is that HTK is not inferior to UW for organ perfusion during procurement in clinical pancreas transplantation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • brain dead, heart beating organ donor
  • donor age 10 - 50 years
  • donor body mass index < 30kg/m2
  • pancreas cold ischemia time < 20 hours
  • written informed consent of the pancreas recipient

排除标准

  • missing written consent
  • pancreas retransplantation
  • recipient participation in another study

结局指标

主要结局

Pancreas graft survival

时间窗: 6 months after transplantation

次要结局

  • Serum amylase(6 months after transplantation)
  • Serum lipase(6 months after transplantation)
  • C-peptide(6 months after transplantation)
  • HbA1c(6 months after transplantation)
  • Exogenous insulin requirement(6 months after transplantation)

研究者

发起方
Medical University Innsbruck
申办方类型
Other

研究点 (8)

Loading locations...

相似试验

Histidine-Tryptophane-Ketoglutarate (HTK) vs... | 临床试验